OK Biotech Co., Ltd. (TPE:4155)
14.65
-0.05 (-0.34%)
Jan 22, 2026, 1:35 PM CST
OK Biotech Revenue
OK Biotech had revenue of 379.58M TWD in the quarter ending September 30, 2025, a decrease of -17.17%. This brings the company's revenue in the last twelve months to 1.64B, up 7.49% year-over-year. In the year 2024, OK Biotech had annual revenue of 1.67B with 40.11% growth.
Revenue (ttm)
1.64B
Revenue Growth
+7.49%
P/S Ratio
1.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.67B | 478.05M | 40.11% |
| Dec 31, 2023 | 1.19B | -291.54M | -19.65% |
| Dec 31, 2022 | 1.48B | 220.15M | 17.43% |
| Dec 31, 2021 | 1.26B | -221.04M | -14.89% |
| Dec 31, 2020 | 1.48B | 243.16M | 19.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.39B |
| InnoCare Optoelectronics | 2.18B |
| Dynamic Medical Technologies | 1.43B |
| WeLeader Biomedical | 1.06B |
| Bioptik Technology Incorporation | 829.18M |
| A Plus Biotechnology | 825.52M |
| Diamond Biotechnology | 698.11M |